Set Analyses:
Advanced Search

Advanced Search

 
Search By
Section (entire)
for


 
or upload a file of gene symbols


Category   Symbol Source: HGNC EntrezGene Ensembl GeneCards RNA genes CroW21
GIFtS

AKT1 Gene

protein-coding   GIFtS: 80
GCID: GC14M105235

V-Akt Murine Thymoma Viral Oncogene Homolog 1

Microbiology & Infectious Diseases Congress
  See related diseases
at  

(According to 1HGNC, 2Entrez Gene,
3UniProtKB/Swiss-Prot, 4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc, 7Ensembl, 8DME, 9miRBase, 10fRNAdb, 12H-InvDB, 13NCBI, 14NONCODE, and/or 15RNAdb)
About This Section

Aliases
V-Akt Murine Thymoma Viral Oncogene Homolog 11 2     CWS62
Protein Kinase B Alpha2 3     PKB-ALPHA2
Proto-Oncogene C-Akt2 3     PRKBA2
PKB2 3     RAC-ALPHA2
RAC2 3     Rac Protein Kinase Alpha2
RAC-PK-alpha2 3     RAC-Alpha Serine/Threonine-Protein Kinase2
PKB Alpha2 3     Protein Kinase B3
EC 2.7.11.13 8     EC 2.7.118
AKT2     

External Ids:    HGNC: 3911   Entrez Gene: 2072   Ensembl: ENSG000001422087   OMIM: 1647305   UniProtKB: P317493   

Export aliases for AKT1 gene to outside databases

Previous GC identifers: GC14M102614 GC14M099226 GC14M103207 GC14M104361 GC14M085432


(According to Entrez Gene, Tocris Bioscience, Wikipedia's Gene Wiki, PharmGKB,
UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL)
About This Section

Entrez Gene summary for AKT1 Gene:
The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary
and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The
activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It
was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT
is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a
transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and
inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus
syndrome. Multiple alternatively spliced transcript variants have been found for this gene. (provided by RefSeq,
Jul 2011)

GeneCards Summary for AKT1 Gene: 
AKT1 (v-akt murine thymoma viral oncogene homolog 1) is a protein-coding gene. Diseases associated with AKT1 include proteus syndrome, and thymoma, and among its related super-pathways are Development EGFR signaling via small GTPases and IL-9 Signaling Pathways. GO annotations related to this gene include enzyme binding and identical protein binding. An important paralog of this gene is RPS6KA6.

UniProtKB/Swiss-Prot: AKT1_HUMAN, P31749
Function: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT
kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and
angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream
substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity
has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced
translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50'
negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the
attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory
14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of
glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in
inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by
which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis
signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative
stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2
at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1
and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead
family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In
particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on
equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and
positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The
phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of
pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby
potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide
phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition
of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho
GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell
proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling
the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron
positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase
(PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF),
epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic
effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and
disassembly. May be involved in the regulation of the placental development. Phosphorylates STK4/MST1 at
'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation
and ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of
its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation.
Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear
translocation. Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity. Phosphorylation of BAD
stimulates its pro-apoptotic activity. Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the
interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53
Function: AKT1-specific substrates have been recently identified, including palladin (PALLD), which
phosphorylation modulates cytoskeletal organization and cell motility; prohibitin (PHB), playing an important
role in cell metabolism and proliferation; and CDKN1A, for which phosphorylation at 'Thr-145' induces its release
from CDK2 and cytoplasmic relocalization. These recent findings indicate that the AKT1 isoform has a more
specific role in cell motility and proliferation. Phosphorylates CLK2 thereby controlling cell survival to
ionizing radiation

summary for AKT1 Gene:
Akt (Protein kinase B, PKB) is a serine/threonine kinase that plays a key in regulating cell survival,
insulin signaling, angiogenesis and tumor formation. Akt is a downstream mediator of the PI 3-K pathway,
resulting in the recruitment of Akt to the plasma membrane via the PH (plexstrin homology domain) of Akt.
Akt is fully activated by phosphorylation at two key sites: Ser308 (phosphorylated by PDK1) and Thr478
(phosphorylated by mTOR and DNA-PK). Akt can then phosphorylated a wide range of substrates including
transcription factors (e.g. FOXO1), kinases (GSK-3, Raf-1, ASK, Chk1) and other proteins with important
signaling roles (e.g. Bad, MDM2). There are three isoforms of Akt; Akt 1, 2 and 3 (also known as PKBalpha,
beta and gamma).

Gene Wiki entry for AKT1 Gene


(According to GeneLoc and/or HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to UCSC (hg19) and Ensembl (release 73), Regulatory elements and Epigenetics data according to QIAGEN, SABiosciences, and/or SwitchGear Genomics)
About This Section
RefSeq DNA sequence:
NC_000014.8  NT_026437.12  NC_018925.2  
Regulatory elements:
   SABiosciences Regulatory transcription factor binding sites in the AKT1 gene promoter:
         CREB   deltaCREB   
         Other transcription factors

SwitchGear Promoter luciferase reporter plasmids (see all 2): AKT1 promoter sequence
   Search SABiosciences Chromatin IP Primers for AKT1

Epigenetics:
QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat AKT1


Genomic Location:
Genomic View: UCSC Golden Path with GeneCards custom track

Entrez Gene cytogenetic band: 14q32.32   Ensembl cytogenetic band:  14q32.33   HGNC cytogenetic band: 14q32.32-q32.33

AKT1 Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)
AKT1 gene location

GeneLoc information about chromosome 14         GeneLoc Exon Structure

GeneLoc location for GC14M105235:  view genomic region     (about GC identifiers)

Start:
105,235,686 bp from pter      End:
105,262,088 bp from pter
Size:
26,403 bases      Orientation:
minus strand

(According to UniProtKB, HORDE, neXtProt, Ensembl, and/or Reactome, Modification sites according to PhosphoSitePlus, Specific Peptides from DME, Protein expression images according to data from SPIRE 1MOPED, 2PaxDb, and 3MAXQB RefSeq according to NCBI, PDB rendering according to OCA and/or Proteopedia, Recombinant Proteins from EMD Millipore, R&D Systems, GenScript, Enzo Life Sciences, OriGene, Novus Biologicals, Sino Biological, ProSpec, and/or Cloud-Clone Corp.,
Biochemical Assays by EMD Millipore, R&D Systems, OriGene, GenScript, Cell Signaling Technology, Enzo Life Sciences, and/or Cloud-Clone Corp., Ontologies according to Gene Ontology Consortium 01 Oct 2013 and Entrez Gene, Antibodies by EMD Millipore, R&D Systems, GenScript, Cell Signaling Technology, OriGene, Novus Biologicals, Thermo Fisher Scientific, LSBio, Abcam, and/or Cloud-Clone Corp.)
About This Section

UniProtKB/Swiss-Prot: AKT1_HUMAN, P31749 (See protein sequence)
Recommended Name: RAC-alpha serine/threonine-protein kinase  
Size: 480 amino acids; 55686 Da
Subunit: Interacts (via the C-terminus) with CCDC88A (via its C-terminus). Interacts with GRB10; the interaction
leads to GRB10 phosphorylation thus promoting YWHAE-binding (By similarity). Interacts with AGAP2 (isoform
2/PIKE-A); the interaction occurs in the presence of guanine nucleotides. Interacts with AKTIP. Interacts (via PH
domain) with MTCP1, TCL1A AND TCL1B. Interacts with CDKN1B; the interaction phosphorylates CDKN1B promoting
14-3-3 binding and cell-cycle progression. Interacts with MAP3K5 and TRAF6. Interacts with BAD, PPP2R5B, STK3 and
STK4. Interacts (via PH domain) with SIRT1. Interacts with SRPK2 in a phosphorylation-dependent manner. Interacts
with RAF1. Interacts with TRIM13; the interaction ubiquitinates AKT1 leading to its proteasomal degradation.
Interacts with TNK2 and CLK2. Interacts (via the C-terminus) with THEM4 (via its C-terminus). Interacts with and
phosphorylated by PDPK1
Subcellular location: Cytoplasm. Nucleus. Cell membrane. Note=Nucleus after activation by integrin-linked protein
kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Phosphorylation on Tyr-176 by TNK2
results in its localization to the cell membrane where it is targeted for further phosphorylations on Thr-308 and
Ser-473 leading to its activation and the activated form translocates to the nucleus
Caution: In light of strong homologies in the primary amino acid sequence, the 3 AKT kinases were long surmised to
play redundant and overlapping roles. More recent studies has brought into question the redundancy within AKT
kinase isoforms and instead pointed to isoform specific functions in different cellular events and diseases. AKT1
is more specifically involved in cellular survival pathways, by inhibiting apoptotic processes; whereas AKT2 is
more specific for the insulin receptor signaling pathway. Moreover, while AKT1 and AKT2 are often implicated in
many aspects of cellular transformation, the 2 isoforms act in a complementary opposing manner. The role of AKT3
is less clear, though it appears to be predominantly expressed in brain
6/21 PDB 3D structures from and Proteopedia for AKT1 (see all 21):
1H10 (3D)        1UNP (3D)        1UNQ (3D)        1UNR (3D)        2UVM (3D)        2UZR (3D)    
Secondary accessions: B2RAM5 Q9BWB6

Explore the universe of human proteins at neXtProt for AKT1: NX_P31749

Explore proteomics data for AKT1 at MOPED 

Post-translational modifications:

  • UniProtKB: O-GlcNAcylation at Thr-305 and Thr-312 inhibits activating phosphorylation at Thr-308 via disrupting the
    interaction between AKT1 and PDPK1. O-GlcNAcylation at Ser-473 also probably interferes with phosphorylation at
    this site
  • UniProtKB: Phosphorylation on Thr-308, Ser-473 and Tyr-474 is required for full activity. Activated TNK2 phosphorylates it on
    Tyr-176 resulting in its binding to the anionic plasma membrane phospholipid PA. This phosphorylated form
    localizes to the cell membrane, where it is targeted by PDPK1 and PDPK2 for further phosphorylations on Thr-308
    and Ser-473 leading to its activation. Ser-473 phosphorylation by mTORC2 favors Thr-308 phosphorylation by PDPK1.
    Ser-473 phosphorylation is enhanced by interaction with AGAP2 isoform 2 (PIKE-A). Ser-473 phosphorylation is
    enhanced in focal cortical dysplasias with Taylor-type balloon cells. Ser-473 phosphorylation is enhanced by
    signaling through activated FLT3. Dephosphorylated at Thr-308 and Ser-473 by PP2A phosphatase. The phosphorylated
    form of PPP2R5B is required for bridging AKT1 with PP2A phosphatase
  • UniProtKB: Ubiquitinated via 'Lys-48'-linked polyubiquitination by ZNRF1, leading to its degradation by the proteasome (By
    similarity). Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. TRAF6-induced
    'Lys-63'-linked AKT1 ubiquitination is critical for phosphorylation and activation. When ubiquitinated, it
    translocates to the plasma membrane, where it becomes phosphorylated. When fully phosphorylated and translocated
    into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the
    proteasome. Also ubiquitinated by TRIM13 leading to its proteasomal degradation
  • UniProtKB: Acetylated on Lys-14 and Lys-20 by the histone acetyltransferases EP300 and KAT2B. Acetylation results in reduced
    phosphorylation and inhibition of activity. Deacetylated at Lys-14 and Lys-20 by SIRT1. SIRT1-mediated
    deacetylation relieves the inhibition
  • View modification sites using PhosphoSitePlus
  • View neXtProt modification sites for NX_P31749

  • 4/35 DME Specific Peptides for AKT1 (P31749) (see all 35)
     VVYRDLK  YYAMKIL  GVVMYEM  AEIVSAL 

    AKT1 Protein expression data from MOPED1, PaxDb2 and MAXQB3 :    About this image 

    AKT1 Protein Expression
    REFSEQ proteins (3 alternative transcripts): 
    NP_001014431.1  NP_001014432.1  NP_005154.2  

    ENSEMBL proteins: 
     ENSP00000451828   ENSP00000384293   ENSP00000270202   ENSP00000385326   ENSP00000450688  
     ENSP00000451470   ENSP00000450681   ENSP00000443897   ENSP00000451166   ENSP00000451290  
     ENSP00000451824  
    Reactome Protein details: P31749
    Human Recombinant Protein Products for AKT1: 
    EMD Millipore Purified and/or Recombinant AKT1 Protein
    R&D Systems Recombinant & Natural Proteins for AKT1
    Enzo Life Sciences proteins for AKT1
    OriGene Purified Proteins for AKT1
    OriGene Protein Over-expression Lysate for AKT1
    OriGene MassSpec for AKT1 
    OriGene Custom Protein Services for AKT1
    GenScript Custom Purified and Recombinant Proteins Services for AKT1
    Novus Biologicals AKT1 Proteins
    Novus Biologicals AKT1 Lysates
    Sino Biological Recombinant Protein for AKT1
    Sino Biological Cell Lysate for AKT1 
    ProSpec Recombinant Protein for AKT1
    Browse Proteins at Cloud-Clone Corp. 

    Gene Ontology (GO): 5/8 cellular component terms (GO ID links to tree view) (see all 8):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0005634nucleus TAS--
    GO:0005654nucleoplasm TAS--
    GO:0005737cytoplasm TAS--
    GO:0005819spindle IEA--
    GO:0005829cytosol TAS--

    AKT1 for ontologies           About GeneDecksing



    AKT1 Antibody Products: 
    EMD Millipore Mono- and Polyclonal Antibodies for the study of AKT1
    R&D Systems Antibodies for AKT1
    Cell Signaling Technology (CST) Antibodies for AKT1 
    OriGene Antibodies for AKT1
    OriGene Custom Antibody Services for AKT1
    GenScript Superior Antibodies for AKT1
    Novus Biologicals AKT1 Antibodies
    Abcam antibodies for AKT1
    Browse Antibodies at Cloud-Clone Corp. 
    ThermoFisher Antibody for AKT1
    LSBio Antibodies in human, mouse, rat for AKT1 

    Assay Products for AKT1: 
    EMD Millipore Kits and Assays for the Analysis of AKT1
    OriGene Custom Assay Services for AKT1
    R&D Systems ELISAs for AKT1         (see all)
    GenScript AKT1-Activity-based Kinase Assay for Compound Screening
    Cell Signaling Technology (CST) Sandwich ELISA Kits for AKT1
    Enzo Life Sciences assays for AKT1
    Browse ELISAs at Cloud-Clone Corp. 
    Browse CLIAs at Cloud-Clone Corp.


    (According to HGNC, IUPHAR, InterPro, ProtoNet, UniProtKB, and/or BLOCKS, Sets of similar genes according to GeneDecks)
    About This Section
    HGNC Gene Families: 
    PLEKH: Pleckstrin homology (PH) domain containing

    IUPHAR Guide to PHARMACOLOGY protein family classification: v-akt murine thymoma viral oncogene homolog 1 
    Protein kinase B

    5/9 InterPro protein domains (see all 9):
     IPR017441 Protein_kinase_ATP_BS
     IPR002290 Ser/Thr_dual-sp_kinase_dom
     IPR000961 AGC-kinase_C
     IPR011009 Kinase-like_dom
     IPR017892 Pkinase_C

    Graphical View of Domain Structure for InterPro Entry P31749

    ProtoNet protein and cluster: P31749

    2 Blocks protein domains:
    IPB000961 Protein kinase C-terminal domain
    IPB001849 Pleckstrin-like


    UniProtKB/Swiss-Prot: AKT1_HUMAN, P31749
    Domain: Binding of the PH domain to phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) following
    phosphatidylinositol 3-kinase alpha (PIK3CA) activity results in its targeting to the plasma membrane. The PH
    domain mediates interaction with TNK2 and Tyr-176 is also essential for this interaction
    Domain: The AGC-kinase C-terminal mediates interaction with THEM4
    Similarity: Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. RAC subfamily
    Similarity: Contains 1 AGC-kinase C-terminal domain
    Similarity: Contains 1 PH domain
    Similarity: Contains 1 protein kinase domain


    AKT1 for domains           About GeneDecksing


    (According to 1UniProtKB, Genatlas, LifeMap Discovery™, IUBMB, and/or 2DME, Human phenotypes from GenomeRNAi, Animal models from MGI Mar 06 2013, inGenious Targeting Laboratory, genOway,
    bound targets from SABiosciences, miRNA Gene Targets from miRTarBase, shRNA from OriGene, RNAi from EMD Millipore, siRNAs from OriGene, QIAGEN, microRNA from QIAGEN, Gene Editing from DNA2.0, Sirion Biotech, Clones from EMD Millipore, OriGene, SwitchGear Genomics, GenScript, Sino Biological, DNA2.0, Vector BioLabs, and Sirion Biotech, Cell Lines from GenScript, LifeMap BioReagents, In Situ Hybridization Assays from Advanced Cell Diagnostics, Ontologies according to Gene Ontology Consortium 01 Oct 2013 via Entrez Gene.)
    About This Section

    Molecular Function:

         UniProtKB/Swiss-Prot Summary: AKT1_HUMAN, P31749
    Function: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT
    kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and
    angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream
    substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity
    has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced
    translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50'
    negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the
    attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory
    14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of
    glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in
    inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by
    which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis
    signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative
    stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2
    at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1
    and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead
    family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In
    particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on
    equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and
    positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The
    phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of
    pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby
    potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide
    phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition
    of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho
    GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell
    proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling
    the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron
    positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase
    (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF),
    epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic
    effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and
    disassembly. May be involved in the regulation of the placental development. Phosphorylates STK4/MST1 at
    'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation
    and ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of
    its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation.
    Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear
    translocation. Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity. Phosphorylation of BAD
    stimulates its pro-apoptotic activity. Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the
    interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53
    Function: AKT1-specific substrates have been recently identified, including palladin (PALLD), which
    phosphorylation modulates cytoskeletal organization and cell motility; prohibitin (PHB), playing an important
    role in cell metabolism and proliferation; and CDKN1A, for which phosphorylation at 'Thr-145' induces its release
    from CDK2 and cytoplasmic relocalization. These recent findings indicate that the AKT1 isoform has a more
    specific role in cell motility and proliferation. Phosphorylates CLK2 thereby controlling cell survival to
    ionizing radiation
    Catalytic activity: ATP + a protein = ADP + a phosphoprotein
    Enzyme regulation: Three specific sites, one in the kinase domain (Thr-308) and the two other ones in the
    C-terminal regulatory region (Ser-473 and Tyr-474), need to be phosphorylated for its full activation. Inhibited
    by pyrrolopyrimidine inhibitors like aniline triazole and spiroindoline
    Biophysicochemical properties: Kinetic parameters: KM=52.8 uM for ATP (for purified and in vitro activated AKT1);
    KM=0.5 uM for peptide substrate (for purified and in vitro activated AKT1); KM=143.3 uM for ATP (for recombinant
    myristoylated AKT1 expressed and immunoprecipitated from Rat-1 cells); KM=2.9 uM for peptide substrate (for
    recombinant myristoylated AKT1 expressed and immunoprecipitated from Rat-1 cells);

         Genatlas biochemistry entry for AKT1:
    V-akt murine thymoma viral oncogen homolog 1,general mediator of cell survival induced by insulin growth factor
    1,AKT1 and others activated by phosphadidylinositol 3-kinase in the antiapoptotic PIK3 pathway,phosphorylating
    and inactivating components of the apoptotic machinery including BAD,CASP9 and the transcription factor FKHRL1

         Enzyme Numbers (IUBMB): EC 2.7.11.11 2 EC 2.7.112

         Gene Ontology (GO): 5/16 molecular function terms (GO ID links to tree view) (see all 16):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0004672protein kinase activity TAS10570282
    GO:0004674protein serine/threonine kinase activity TAS--
    GO:0004713protein tyrosine kinase activity ----
    GO:0005080protein kinase C binding IEA--
    GO:0005515protein binding IPI11154276
         
    AKT1 for ontologies           About GeneDecksing


    Phenotypes:
         6 GenomeRNAi human phenotypes for AKT1:
     Decreased p24 protein expressi  Decreased viability after Chla  Decreased viability with TRAIL  Increases Tamoxifen sensitivit 
     Weaker migration  Wnt reporter downregulated 

         15/20 MGI mutant phenotypes (inferred from 7 alleles(MGI details for Akt1) (see all 20):
     adipose tissue  behavior/neurological  cardiovascular system  cellular  embryogenesis 
     endocrine/exocrine gland  growth/size  hematopoietic system  homeostasis/metabolism  immune system 
     integument  liver/biliary system  mortality/aging  muscle  nervous system 

    AKT1 for phenotypes           About GeneDecksing

    Animal Models:
         MGI mouse knock-outs for AKT1: Akt1tm1Nhy Akt1tm1Mbb Akt1tm2.1Mbb

       inGenious Targeting Laboratory - Custom generated mouse model solutions for AKT1 
       inGenious Targeting Laboratory - Custom generated inducible mouse model solutions for AKT1

       genOway customized KO model: permanent, tissue-specific or time-controlled inactivation for AKT1 
       genOway customized Knockin model: humanization, point mutation, expression monitoring, etc. for AKT1 

    miRNA
    Products:
        
    miRTarBase miRNAs that target AKT1:
    hsa-mir-451 (MIRT005740), hsa-mir-125b (MIRT004363), hsa-mir-185 (MIRT004701), hsa-mir-149 (MIRT005355)

    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat AKT1
    8/21 QIAGEN miScript miRNA Assays for microRNAs that regulate AKT1 (see all 21):
    hsa-miR-520e hsa-miR-302d hsa-miR-374a hsa-miR-302e hsa-miR-520a-3p hsa-miR-633 hsa-miR-372 hsa-miR-520d-3p
    SwitchGear 3'UTR luciferase reporter plasmidAKT1 3' UTR sequence
    Inhib. RNA
    Products:
        
    EMD Millipore RNAi Products for the Analysis of AKT1 Gene knock-down
    OriGene RNAi products in human, mouse, rat for AKT1
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat AKT1

    Gene Editing
    Products:
    DNA2.0 Custom Protein Engineering Service for AKT1
    Sirion Biotech Validated adenovirus to knockdown AKT1 in human, mouse 
                         Customized adenovirus for overexpression of AKT1

    Clone
    Products:
         
    Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
    OriGene clones in human, mouse for AKT1 (see all 20)
    OriGene ORF clones in mouse, rat for AKT1
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector (see all 3): AKT1 (NM_005163)
    Sino Biological Human cDNA Clone for AKT1
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for AKT1
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat AKT1
    Sirion Biotech Customized lentivirus for stable overexpression of AKT1 
                         Customized lentivirus expression plasmids for stable overexpression of AKT1 

    Cell Line
    Products:
         
    GenScript Custom overexpressing Cell Line Services for AKT1
    Search LifeMap BioReagents cell lines for AKT1
    In Situ Assay
    Products:
       

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for AKT1


    (Pathways according to EMD Millipore, R&D Systems, Cell Signaling Technology, KEGG, PharmGKB, BioSystems, Sino Biological, Reactome, Tocris Bioscience, GeneGo (Thomson Reuters), QIAGEN, and/or UniProtKB, Sets of similar genes according to GeneDecks, Interaction Networks according to SABiosciences, and/or STRING, Interactions according to 1UniProtKB, 2MINT, 3I2D, and/or 4STRING, with links to IntAct and Ensembl, Ontologies according to Gene Ontology Consortium 01 Oct 2013 via Entrez Gene).
    About This Section

    SuperPaths for AKT1 About   (see all 235)                                                                                              See pathways by source

    SuperPathSelected contained pathways About (see all per SuperPath)
    1Development HGF signaling pathway
    Development HGF signaling pathway0.78
    Neurotrophin signaling pathway0.36
    Development Neurotrophin family signaling0.45
    Apoptosis and survival Anti-apoptotic action of membrane-bound ESR10.35
    Development EGFR signaling via PIP30.40
    Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)0.31
    Apoptosis and survival Role of CDK5 in neuronal death and survival0.37
    Renal cell carcinoma0.30
    2Common Cytokine Receptor Gamma-Chain Family Signaling Pathways
    IL-9 Signaling Pathways0.90
    IL-4 Signaling Pathways0.84
    IL-7 Signaling Pathways0.90
    IL-9 Signaling Pathway0.42
    IL-21 Signaling Pathways0.90
    IL-7 Signaling Pathway0.40
    Common Cytokine Receptor Gamma-Chain Family Signaling Pathways0.90
    Development Thrombopoietin-regulated cell processes0.38
    3Translation Insulin regulation of translation
    Translation Insulin regulation of translation0.59
    Cell adhesion PLAU signaling0.35
    Regulation of lipid metabolism Insulin signaling:generic cascades0.59
    Development Growth hormone signaling via PI3K/AKT and MAPK cascades0.34
    Transcription Receptor-mediated HIF regulation0.51
    mTOR signaling pathway0.34
    Translation Regulation activity of EIF20.47
    Insulin signaling pathway0.31
    4Immune response Fc epsilon RI pathway
    Immune response Fc epsilon RI pathway0.45
    VEGF signaling pathway0.39
    Immune response BCR pathway0.45
    Immune response IL-4 signaling pathway0.38
    Fc epsilon RI signaling pathway0.40
    Fc-epsilon receptor I signaling in mast cells0.33
    5B cell receptor signaling pathway
    B cell receptor signaling pathway0.42
    T cell receptor signaling pathway0.38
    BCR signaling pathway0.42
    TCR Signaling Pathway0.35

    Pathways by source                                                                                                                                                                 See SuperPaths
    Show all pathways

    5/67 EMD Millipore Pathways for AKT1 (see all 67)
        Cytoskeleton remodeling FAK signaling
    G-protein signaling G-Protein beta/gamma signaling cascades
    Transcription NF-kB signaling pathway
    Development A2A receptor signaling
    Immune response IL-4 signaling pathway

    5/12 R&D Systems Pathways for AKT1 (see all 12)
        IL-21 Signaling Pathways
    IL-2 Signaling Pathways
    IL-4 Signaling Pathways
    Adipocytokines & Insulin Signaling
    Akt Signaling Pathway

    5/90 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for AKT1 (see all 90)
        Telomerase Components in Cell Signaling
    UVB-Induced MAPK Signaling
    Molecular Mechanisms of Cancer
    eIF2 Pathway
    ERK5 Signaling

    2 Cell Signaling Technology (CST) Pathways for AKT1
        PI3K / Akt Signaling
    Glucose / Energy Metabolism

    5/8 Tocris Bioscience Pathways for AKT1 (see all 8)
        Akt Pathway
    Insulin Pathway
    Toll-like Receptor Pathway
    Apoptosis Pathway
    TGF-beta Pathway

    5/70 GeneGo (Thomson Reuters) Pathways for AKT1 (see all 70)
        Development A2A receptor signaling
    Development CNTF receptor signaling
    Apoptosis and survival Anti-apoptotic action of membrane-bound ESR1
    Development EGFR signaling pathway
    Signal transduction AKT signaling

    5/106 BioSystems Pathways for AKT1 (see all 106)
        TOR signaling
    Angiogenesis
    MAPK signaling pathway
    Focal Adhesion
    MicroRNAs in cardiomyocyte hypertrophy

    5/6 Sino Biological Pathways for AKT1 (see all 6
        TNF Signaling
    EGFR Signaling Pathway
    p53 Pathway
    VEGF Signaling
    Death Receptor Signaling

    5/70        Reactome Pathways for AKT1 (see all 70)
        Downregulation of ERBB2:ERBB3 signaling
    Intrinsic Pathway for Apoptosis
    Signaling by PDGF
    Downstream Signaling Events Of B Cell Receptor (BCR)
    Signalling by NGF

    5 PharmGKB Pathways for AKT1
        Anti-diabetic Drug Potassium Channel Inhibitors Pathway, Pharmacodynamics
    Celecoxib Pathway, Pharmacodynamics
    EGFR Inhibitor Pathway, Pharmacodynamics
    Sorafenib Pharmacodynamics
    VEGF Signaling Pathway

    5/50         Kegg Pathways  (Kegg details for AKT1) (see all 50):
        MAPK signaling pathway
    ErbB signaling pathway
    Chemokine signaling pathway
    HIF-1 signaling pathway
    mTOR signaling pathway


    AKT1 for pathways           About GeneDecksing

    Interactions:

        SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for AKT1

    STRING Interaction Network Preview (showing 5 interactants - click image to see 25)

    5/372 Interacting proteins for AKT1 (P317491, 2, 3 ENSP000002702024) via UniProtKB, MINT, STRING, and/or I2D (see all 372)
    InteractantInteraction Details
    GeneCardExternal ID(s)
    STK4Q130432, 3, ENSP000003618924MINT-6175011 MINT-6175193 MINT-6175251 MINT-6175225 MINT-6174722 MINT-6175034 MINT-6175070 MINT-6175132 MINT-6175047 MINT-6175025 MINT-6175115 MINT-6175085 MINT-6175239 I2D: score=2 STRING: ENSP00000361892
    SORBS2O948752, 3, ENSP000002847764MINT-61344 MINT-61469 MINT-61464 MINT-61466 MINT-61479 MINT-61468 MINT-61467 MINT-61463 MINT-61346 MINT-61345 MINT-61462 MINT-61465 I2D: score=2 STRING: ENSP00000284776
    PLCG1P191742, 3, ENSP000002440074MINT-7146749 MINT-7146647 MINT-7146716 MINT-7146688 MINT-7146767 MINT-7146702 MINT-7146731 MINT-7146657 MINT-7146671 I2D: score=1 STRING: ENSP00000244007
    MDM2Q009871, 2, 3, ENSP000004172814EBI-296087,EBI-389668 MINT-6823537 MINT-50904 MINT-50905 I2D: score=5 STRING: ENSP00000417281
    GSK3BP498411, 2, 3, ENSP000003248064EBI-296087,EBI-373586 MINT-8392173 I2D: score=6 STRING: ENSP00000324806
    About this table

    Gene Ontology (GO): 5/104 biological process terms (GO ID links to tree view) (see all 104):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0000060protein import into nucleus, translocation IMP16280327
    GO:0001649osteoblast differentiation IEA--
    GO:0001893maternal placenta development IEA--
    GO:0001934positive regulation of protein phosphorylation IDA19057511
    GO:0005977glycogen metabolic process ----

    AKT1 for ontologies           About GeneDecksing



    (Chemical Compounds according to UniProtKB, Enzo Life Sciences, EMD Millipore, Tocris Bioscience HMDB, BitterDB, and/or Novoseek, Ligands according to IUPHAR, and Drugs according to DrugBank, Enzo Life Sciences, and/or PharmGKB, with drugs/clinical trials/news search links to CenterWatch)
    About This Section

    AKT1 for compounds           About GeneDecksing

    EMD Millipore small molecules for AKT1:
    Small Molecule - inhibitor
    Browse drugs & compounds from Enzo Life Sciences

    Compounds for AKT1 available from Tocris Bioscience    About this table
    CompoundAction CAS #
    10-DEBC hydrochlorideSelective Akt/PKB inhibitor[201788-90-1]
    API-2Selective inhibitor of Akt/PKB signaling. Antitumor and antiviral[35943-35-2]
    FPA 124Akt/PKB inhibitor[902779-59-3]
    API-1Selective Akt/PKB inhibitor. Antitumor[36707-00-3]
    SC 79Akt activator[305834-79-1]

    3 HMDB Compounds for AKT1    About this table
    CompoundSynonyms CAS #PubMed Ids
    ADPadenosindiphosphorsaeure (see all 8)58-64-0--
    Adenosine triphosphate5'-(tetrahydrogen triphosphate) Adenosine (see all 24)56-65-5--
    SumatriptanImigran (see all 4)103628-46-2--

    5 DrugBank Compounds for AKT1    About this table
    CompoundSynonyms CAS #TypeActionsPubMed Ids
    Arsenic trioxideAcide Arsenieux [French] (see all 11)1327-53-3targetinducer16239170 12472888 15580309 12529330 15916724
    Inositol 1,3,4,5-Tetrakisphosphate-- --target--17139284 17016423
    5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-- --target--10592235
    Adenosine triphosphate5'-ATP (see all 8)56-65-5target--17041888
    N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine-- --target--10592235

    1 IUPHAR Ligand for AKT1 (v-akt murine thymoma viral oncogene homolog 1)    About this table 
    LigandTypeActionAffinityPubmed IDs
    GSK690693
    InhibitorInhibition18800763

    10/125 Novoseek inferred chemical compound relationships for AKT1 gene (see all 125)    About this table
    Compound   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    phosphatidylinositol 88.5 246 12551955 (5), 10578066 (5), 8645157 (3), 10671514 (3) (see all 99)
    phosphoinositide 83.7 125 10454216 (4), 10102683 (3), 9671484 (2), 15292195 (2) (see all 88)
    ly294002 83.6 78 15752900 (3), 15347471 (3), 16842970 (3), 10623881 (2) (see all 48)
    wortmannin 83.4 88 17380453 (3), 16458614 (2), 9346964 (2), 9755080 (2) (see all 62)
    threonine 78 116 10362672 (1), 10411946 (1), 10491192 (1), 11279265 (1) (see all 99)
    phosphatidylinositol-3,4,5-trisphosphate 77.6 20 7738099 (1), 15107457 (1), 9228007 (1), 12421919 (1) (see all 18)
    serine 71.1 120 16780593 (3), 16141217 (2), 10362672 (1), 10411946 (1) (see all 99)
    rapamycin 70 48 10623881 (2), 17565979 (2), 10567225 (2), 17616691 (2) (see all 35)
    glycogen 69.9 112 11574400 (5), 10623881 (4), 9478990 (3), 10446195 (2) (see all 68)
    tyrosine 69.3 113 9593727 (3), 7616102 (3), 9415029 (3), 10623881 (2) (see all 79)

    1 PharmGKB related drug/compound annotation for AKT1 gene    About this table
    Drug/compound PharmGKB Annotation
    risperidoneCA  

    Search CenterWatch for drugs/clinical trials and news about AKT1

    (Secondary structures according to fRNAdb,
    GenBank/EMBL/DDBJ Accessions according to
    Unigene (Build 236 Homo sapiens; Apr 25 2013) or GenBank,
    RefSeq according to Entrez Gene,
    DOTS (version 10), and/or AceView, transcript ids from Ensembl with links to UCSC,
    Conferences by KenesGroup, exon structure from GeneLoc, alternative splicing isoforms according to ASD and/or ECgene,
    RNAi Products from EMD Millipore,
    siRNAs from OriGene, QIAGEN, shRNA from OriGene, microRNA from QIAGEN,
    Tagged/untagged cDNA clones from OriGene, SwitchGear Genomics, GenScript, DNA2.0, Vector BioLabs, Sirion Biotech, Primers from OriGene, SABiosciences, and/or QIAGEN )
    About This Section

    REFSEQ mRNAs for AKT1 gene (3 alternative transcripts): 
    NM_001014431.1  NM_001014432.1  NM_005163.2  

    Unigene Cluster for AKT1:

    V-akt murine thymoma viral oncogene homolog 1
    Hs.525622  [show with all ESTs]
    Unigene Representative Sequence: AK122894
    18 Ensembl transcripts including schematic representations, and UCSC links where relevant:
    ENST00000554581(uc001ypk.3 uc001ypl.3) ENST00000407796 ENST00000349310(uc001ypm.3 uc001ypn.3)
    ENST00000553506 ENST00000557552(uc001ypj.3 uc010tyk.2) ENST00000402615(uc010axa.3)
    ENST00000555528 ENST00000555458 ENST00000554192 ENST00000544168 ENST00000554585
    ENST00000554848 ENST00000554826 ENST00000556836 ENST00000555380 ENST00000555926
    ENST00000557494 ENST00000553797
    Congresses - knowledge worth sharing:  
    European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 10 - 13 May 2014

    miRNA
    Products:
         
    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat AKT1
    8/21 QIAGEN miScript miRNA Assays for microRNAs that regulate AKT1 (see all 21):
    hsa-miR-520e hsa-miR-302d hsa-miR-374a hsa-miR-302e hsa-miR-520a-3p hsa-miR-633 hsa-miR-372 hsa-miR-520d-3p
    SwitchGear 3'UTR luciferase reporter plasmidAKT1 3' UTR sequence
    Inhib. RNA
    Products:
         
    EMD Millipore RNAi Products for the Analysis of AKT1 Gene knock-down
    OriGene RNAi products in human, mouse, rat for AKT1
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat AKT1
    Clone
    Products:
         
    OriGene clones in human, mouse for AKT1 (see all 20)
    OriGene ORF clones in mouse, rat for AKT1
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector (see all 3): AKT1 (NM_005163)
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for AKT1
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat AKT1
    Sirion Biotech Customized lentivirus for stable overexpression of AKT1 
                         Customized lentivirus expression plasmids for stable overexpression of AKT1 
    Primer
    Products:
        
    OriGene qPCR primer pairs and template standards for AKT1
    OriGene qSTAR qPCR primer pairs in human, mouse for AKT1
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat AKT1
      QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat AKT1
      QIAGEN QuantiFast Probe-based Assays in human, mouse, rat AKT1

    Additional mRNA sequence: 

    AB451242.1 AB451367.1 AK122894.1 AK299310.1 AK314256.1 BC000479.2 BC001737.1 BC063408.1 
    BC084538.1 BX648205.1 M63167.1 X61037.1 

    24 DOTS entries:

    DT.450038  DT.100059722  DT.100824191  DT.100059719  DT.95090241  DT.100733482  DT.120765970  DT.92461206 
    DT.100824190  DT.100824203  DT.102829546  DT.100824201  DT.75100119  DT.95341680  DT.100059721  DT.120765944 
    DT.95090231  DT.95090239  DT.95090245  DT.120765955  DT.120765973  DT.92461194  DT.92461227  DT.95124889 

    13 AceView cDNA sequences:

    BX648205 CR611982 BC001737 BC000479 AK131465 AK094287 NM_005163 BX647722 
    M63167 AK122894 AK127193 X61037 BC063408 

    GeneLoc Exon Structure

    5/10 Alternative Splicing Database (ASD) splice patterns (SP) for AKT1 (see all 10)    About this scheme

    ExUns: 1 ^ 2 ^ 3 ^ 4 ^ 5a · 5b · 5c ^ 6a · 6b ^ 7a · 7b ^ 8 ^ 9a · 9b · 9c ^ 10a · 10b · 10c ^ 11a · 11b ^ 12 ^ 13a · 13b ^ 14a · 14b ^ 15 ^
    SP1:                                                                                      -     -                                                               
    SP2:                                                                                      -     -                                                           -   
    SP3:                                                                                      -     -                                                               
    SP4:                                                                                -     -     -                                                               
    SP5:                                                                                                                                -                       -   

    ExUns: 16 ^ 17a · 17b ^ 18
    SP1:                        
    SP2:                        
    SP3:                        
    SP4:                        
    SP5:                        


    ECgene alternative splicing isoforms for AKT1

    (RNA expression data according to H-InvDB, NONCODE, miRBase, and RNAdb, Expression images according to data from BioGPS, Illumina Human BodyMap, and CGAP SAGE, Sets of similar genes according to GeneDecks, in vivo and in vitro expression data from LifeMap Discovery™, plus additional links to Genevestigator, and/or SOURCE, and/or BioGPS, and/or UniProtKB,
    PCR Arrays from SABiosciences, Primers from OriGene, SABiosciences, and/or QIAGEN, In Situ Hybridization Assays from Advanced Cell Diagnostics)
    About This Section

    AKT1 expression in normal human tissues (normalized intensities)      AKT1 embryonic expression: see
    See probesets specificity/sensitivity at GeneAnnot
    About this imageBioGPS <intensity>2/3
    CGAP TAG: --
    AKT1 Expression
    About this image


    AKT1 expression in embryonic tissues and stem cells    About this table
    Data from LifeMap, the Embryonic Development and Stem Cells Database 
     5/4 selected tissues (see all 4) fully expand
     
     Endothelium (Cardiovascular System)    fully expand to see all 2 entries
             Angioblasts Embryonic Capillary Plexus
     
     Lateral Plate Mesoderm (Gastrulation Derivatives)    fully expand to see all 2 entries
             Angioblasts Embryonic Capillary Plexus
     
     Brain (Nervous System)
             brain/hindbrain   
     
     Oral Cavity (Gastrointestinal Tract)
             salivary gland   

    See AKT1 Protein Expression from SPIRE MOPED and PaxDB
    Genevestigator expression for AKT1

    SOURCE GeneReport for Unigene cluster: Hs.525622

    UniProtKB/Swiss-Prot: AKT1_HUMAN, P31749
    Tissue specificity: Expressed in prostate cancer and levels increase from the normal to the malignant state (at
    protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a
    significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia
    (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages

        SABiosciences Expression via Pathway-Focused PCR Arrays including AKT1 (see all 37): 
              Lung Cancer in human mouse rat
              Insulin Signaling Pathway in human mouse rat
              Prostate Cancer in human mouse rat
              Mitochondria in human mouse rat
              Breast Cancer in human mouse rat

    Primer
    Products:
    OriGene qPCR primer pairs and template standards for AKT1
    OriGene qSTAR qPCR primer pairs in human, mouse for AKT1
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat AKT1
    QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat AKT1
    QIAGEN QuantiFast Probe-based Assays in human, mouse, rat AKT1
    In Situ
    Assay Products:
     

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for AKT1

    (Orthologs according to 1,2HomoloGene (2older version, for species not in 1newer version), 3euGenes, 4SGD , 5MGI Mar 06 2013, with possible further links to Flybase and/or WormBase, and/or 6Ensembl pan taxonomic compara , Gene Trees according to Ensembl and TreeFam)
    About This Section

    This gene was present in the common ancestor of animals.

    Orthologs for AKT1 gene from 7/14 species (see all 14)    About this table
    Organism Taxonomic
    classification
    Gene Description Human
    Similarity
    Orthology
    Type
    Details
    mouse
    (Mus musculus)
    Mammalia Akt11 , 5 thymoma viral proto-oncogene 11, 5 90.9(n)1
    98.33(a)1
      12 (61.20 cM)5
    116511  NM_009652.31  NP_033782.11 
     1126538215 
    chicken
    (Gallus gallus)
    Aves AKT11 v-akt murine thymoma viral oncogene homolog 1 76.94(n)
    96.04(a)
      395928  NM_205055.1  NP_990386.1 
    lizard
    (Anolis carolinensis)
    Reptilia AKT16
    Uncharacterized protein
    96(a)
    1 ↔ 1
    1(3696188-3809503)
    African clawed frog
    (Xenopus laevis)
    Amphibia AF317656.12   -- 76.92(n)    AF317656.1 
    zebrafish
    (Danio rerio)
    Actinopterygii akt2l1 v-akt murine thymoma viral oncogene homolog 2, like 76.02(n)
    77.22(a)
      403146  NM_212815.1  NP_997980.1 
    fruit fly
    (Drosophila melanogaster)
    Insecta Akt13 anti-apoptosis protein serine/threonine
    kinase
    61(a)   89B6   --
    worm
    (Caenorhabditis elegans)
    Secernentea akt-11 , 3 PH (pleckstrin homology) domain,
    Protein kinase more3
    Protein AKT-11
    55(a)
    (best of 2)3
    55.84(n)1
    59.62(a)1
      V(10251544-10255039)3
    1794241  NM_001028474.31  NP_001023645.11 


    ENSEMBL Gene Tree for AKT1 (if available)
    TreeFam Gene Tree for AKT1 (if available)

    (Paralogs according to 1HomoloGene,
    2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68)
    About This Section
    Paralogs for AKT1 gene
    RPS6KA62  RPS6KB12  SGK32  C8orf44-SGK32  SGK22  RPS6KA12  RPS6KA52  AKT32  
    RPS6KA42  SGK12  RPS6KB22  RPS6KA22  RPS6KA32  AKT22  
    18/76 SIMAP similar genes for AKT1 using alignment to 7 protein entries:     AKT1_HUMAN (see all proteins) (see all similar genes):
    AKT2    AKT3    KIN27    PRKCH    PRKCZ    SGK2
    PRKACB    PRKCA    PKN2    PRKCE    PKN1    PRKACA
    PRKCI    RPS6KA2    DKFZp781N0293    SGK3    SGKL    MARK4

    AKT1 for paralogs           About GeneDecksing



    (SNPs/Variants according to the 1NCBI SNP Database, 2Ensembl, 3PupaSUITE, 4UniProtKB, and DNA2.0, Linkage Disequilibrium by HapMap, Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene Mutation Database (HGMD) and the Locus Specific Mutation Databases (LSDB), Blood group antigen gene mutations by BGMUT, Resequencing Primers from QIAGEN, Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
    About This Section

    10/512 SNPs in AKT1 are shown (see all 512)    About this table     
    Genomic DataTranscription Related DataAllele Frequencies
    SNP IDValidClinical
    significance
    Chr 14 posSequence#AA
    Chg
    TypeMore#Allele
    freq
    PopTotal
    sample
    More
    ----------
    rs1214345921,2,4
    CProteus syndrome (PROTEUSS)4 pathogenic1105246551(-) TAGGGA/GAGTAC 6 K E mis10--------
    rs617612541,2
    C,F--105235233(-) GCCAAG/CGTCAT 3 -- ds50013Minor allele frequency- C:0.15NS WA 210
    rs1467312121,2
    --105235369(+) CTGGGG/TTGAAG 3 -- ds50010--------
    rs24988011,2
    C,F,A--105235558(-) CCCCAA/GCAGGT 3 -- ds50018Minor allele frequency- G:0.46NA NS CSA WA EA 451
    rs617612531,2
    C,F--105235640(-) GGAGGG/CAGTGG 3 -- ds50013Minor allele frequency- C:0.01NS WA 212
    rs1906051781,2
    --105235787(+) GTGGTA/GCAGCG 3 -- ut310--------
    rs1403207431,2
    --105235791(+) TGCAGC/TGGCAG 3 -- ut310--------
    rs1833602001,2
    --105235804(+) GCAGCA/GTCTGG 3 -- ut310--------
    rs178468291,2
    C,F--105235818(-) TCCACG/ACCTCC 3 -- ut31 ese35Minor allele frequency- A:0.13NS NA WA 254
    rs585652161,2
    C,F--105235824(+) GTGGAG/CGGGCC 3 -- ut314Minor allele frequency- C:0.25NS WA 208

    HapMap Linkage Disequilibrium report for AKT1 (105235686 - 105262088 bp)

    Structural Variations
         Database of Genomic Variants (DGV) 10/13 variations for AKT1 (see all 13):    About this table     
    Variant IDTypeSubtypePubMed ID
    esv2749227CNV Deletion23290073
    dgv2017n71CNV Loss21882294
    dgv2016n71CNV Loss21882294
    dgv2015n71CNV Loss21882294
    nsv517038CNV Loss19592680
    dgv2009n71CNV Loss21882294
    dgv2012n71CNV Loss21882294
    nsv470677CNV Loss18288195
    nsv456455CNV Loss19166990
    nsv902389CNV Loss21882294


    Human Gene Mutation Database (HGMD): AKT1
    4 SABiosciences Cancer Mutation PCR Assays for AKT1:
    Cosmic IdAA Change
    33765p.E17K
    36918p.E49K
    33765p.E17K
    48226p.F35L
    5/19 SABiosciences Cancer Mutation PCR Arrays containing AKT1 (see all 19):
    Breast Cancer
    Receptor Tyrosine Kinase (RTK) (Panel II)
    Cancer Comprehensive Panel 384HT
    Lung Cancer
    KIT Pathway
    4 SABiosciences qBiomarker Copy Number PCR Arrays containing AKT1:
    Oncogenes & Tumor Suppressor Genes 384HC
    Breast Cancer
    Lung Cancer
    Kinases & Phosphatases
    SeqTarget long-range PCR primers for resequencing AKT1
    DNA2.0 Custom Variant and Variant Library Synthesis for AKT1

    (in which this Gene is Involved, According to MalaCards, OMIM, UniProtKB, the University of Copenhagen DISEASES database, Conferences by KenesGroup, Novoseek, Genatlas, GeneTests, GAD, HuGE Navigator, and/or TGDB.)
    About This Section
    OMIM gene information: 164730   
    OMIM disorders: 114480  114500  604370  181500  
    UniProtKB/Swiss-Prot: AKT1_HUMAN, P31749
  • Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast
    neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common
    type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated
    by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different
    families or even in the same case. Note=Disease susceptibility is associated with variations affecting the gene
    represented in this entry
  • Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from
    the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with
    progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon
    and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene
    represented in this entry may be involved in disease pathogenesis
  • Note=Genetic variations in AKT1 may play a role in susceptibility to ovarian cancer
  • Proteus syndrome (PROTEUSS) [MIM:176920]: A highly variable, severe disorder of asymmetric and
    disproportionate overgrowth of body parts, connective tissue nevi, epidermal nevi, dysregulated adipose tissue,
    and vascular malformations. Many features of Proteus syndrome overlap with other overgrowth syndromes. Note=The
    disease is caused by mutations affecting the gene represented in this entry

  • 20/192 diseases for AKT1 (see all 192):    About MalaCards
    proteus syndrome    thymoma    anal squamous cell carcinoma    overnutrition
    serous cystadenocarcinoma    ovarian serous cystadenocarcinoma    breast cancer    breast cancer, somatic
    colorectal cancer, somatic    cystadenocarcinoma    alexia    vascular malformations
    leopard syndrome    salivary gland cancer    cowden disease    diffuse astrocytoma
    psychotic disorder    megakaryocytic leukemia    ovarian epithelial cancer    smooth muscle tumor

    20/29 diseases from the University of Copenhagen DISEASES database for AKT1 (see all 29):
    Vascular disease     Breast cancer     Diabetes mellitus     Prostate cancer
    Malignant glioma     Lung cancer     Leukemia     Carcinoma
    Heart disease     Hyperglycemia     Hepatocellular carcinoma     Colorectal cancer
    Ovarian cancer     Melanoma     Pancreatic cancer     Lymphoma
    Brain disease     Neuroblastoma     Retinoblastoma     Thymoma

    AKT1 for disorders           About GeneDecksing


    Congresses - knowledge worth sharing:  
    The International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) 9 - 13 March 2014
    Alzheimer's & Parkinson's Diseases Congress (ADPD) 18 - 22 March 2015

    84 Novoseek inferred disease relationships for AKT1 gene (see top 10)    About this table

    Disease   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    cancer 53.2 97 11571628 (5), 19216065 (3), 19876913 (3), 17611497 (3) (see all 66)
    insulin resistance 47.2 15 15634339 (2), 10373517 (1), 20101593 (1), 11274905 (1) (see all 14)
    wiskott-aldrich syndrome 47.1 7 15657136 (1), 10488099 (1), 18198193 (1), 11580754 (1) (see all 7)
    tumors 45 142 17027002 (4), 12191616 (4), 11593437 (4), 17639041 (4) (see all 80)
    glioblastoma 36.1 7 10958682 (2), 11439092 (1), 18250332 (1), 19234490 (1) (see all 5)
    breast cancer 34.4 50 16782806 (5), 16711509 (3), 18087195 (3), 16428439 (3) (see all 30)
    thymoma 29.8 12 16251502 (1), 15522255 (1), 17464696 (1), 17611497 (1) (see all 10)
    metastasis 27.4 17 19305425 (2), 15886842 (2), 19487299 (1), 20360004 (1) (see all 13)
    insulin sensitivity 27.2 2 18599621 (1), 18573875 (1)
    hyperinsulinemia 22.8 1 17513702 (1)
    astrocytoma 18.7 4 16186116 (1), 10749665 (1), 11694521 (1)
    prostate cancer 18.3 27 16253776 (4), 20102399 (3), 16721361 (3), 19305425 (2) (see all 12)
    endometrial carcinoma 15.7 2 19491896 (1), 19853286 (1)
    glioma 15.6 14 16828967 (2), 19925030 (2), 16773187 (1), 17041888 (1) (see all 10)
    tuberous sclerosis 13.7 3 16545079 (1), 19143635 (1), 17346240 (1)
    ovarian cancer 13.4 7 20101210 (1), 10075725 (1), 17611497 (1), 16894566 (1) (see all 7)
    leukemia t-cell 13.3 4 15169787 (1), 10716693 (1), 11707444 (1)
    pancreatic cancer 10.5 3 18783292 (2), 16789737 (1)
    retinoblastoma 10.1 6 19420344 (3), 17027002 (2), 9668055 (1)
    colon cancer 9.65 8 15888491 (2), 18413665 (1), 17825155 (1), 16202996 (1) (see all 6)
    schizophrenia 8.61 61 17825267 (6), 17464696 (5), 18635704 (5), 15522255 (4) (see all 21)
    breast carcinoma 8.43 9 19418217 (3), 10424760 (3), 16682946 (1), 20102399 (1)
    hepatocellular carcinoma 7.67 4 16094707 (2), 14654898 (1), 16322309 (1)
    malignant glioma 6.97 1 10435616 (1)
    pathological processes 6.84 3 18325479 (1), 9388204 (1)
    scar 5.52 5 17319906 (1), 19633175 (1), 20197404 (1)
    atherosclerosis 5.51 3 12958025 (1), 15385541 (1)
    colorectal cancer 4.46 5 16202996 (2), 15888491 (1), 20133737 (1)
    ischemia 4.2 1 15797868 (1)
    somatic mutations 3.8 5 17047397 (1), 18783292 (1), 17611497 (1), 19420344 (1) (see all 5)
    neurofibromatosis type 2 3.47 1 17234759 (1)
    cancer lung 3.23 9 17616691 (4), 19491896 (1), 18391978 (1), 19802009 (1) (see all 6)
    hyperglycemia 3 1 11914741 (1)
    inflammation 2.64 6 15149850 (2), 14730361 (1)
    rhabdomyosarcoma 1.86 2 12196101 (1), 17696196 (1)
    heart failure 1.68 4 19292054 (2), 16921028 (1)
    immunodeficiency 1.44 1 8805223 (1)
    rheumatoid arthritis 1.26 1 17599731 (1)
    parkinson disease 1.17 1 19800394 (1)
    stroke 0.312 2 19440551 (1), 11686294 (1)
    cardiovascular diseases 0 2 12958025 (1)
    niddm 0 5 15322693 (3), 11508278 (2)
    thyroid cancer 0 4 19487299 (3), 17481480 (1)
    leukemia 0 7 12592338 (2), 15964830 (1), 17611497 (1), 17921701 (1) (see all 5)
    carcinoma squamous cell 0 6 7702629 (1), 17804734 (1), 19628421 (1), 16775008 (1)
    pancreatic tumor 0 1 16789737 (1)
    epithelial tumor 0 1 11551917 (1)
    pancreatic carcinoma 0 1 10454216 (1)
    fibrosarcoma 0 1 14769036 (1)
    diabetic retinopathy 0 1 16216433 (1)
    necrosis 0 6 10446216 (2), 9618155 (1), 11453646 (1), 17284447 (1) (see all 5)
    shock 0 14 9237690 (3), 9806907 (3), 11429232 (2), 10373517 (1) (see all 6)
    granulomatous disease chronic 0 1 8148304 (1)
    huntington disease 0 1 12624792 (1)
    breast cancer metastatic 0 5 16280046 (3)
    primary tumor 0 2 19487299 (1), 16166444 (1)
    hypertrophy 0 5 16269655 (1), 17021050 (1), 11158304 (1), 12958025 (1)
    bipolar disorder 0 2 18466879 (1), 16964080 (1)
    gastric carcinoma 0 1 14678019 (1)
    myeloma 0 2 19996089 (1), 15701825 (1)
    mammary tumor 0 11 14691145 (2), 15126356 (2), 17210696 (1), 8455596 (1)
    neurodegenerative diseases 0 3 9681462 (1), 17289346 (1), 19585524 (1)
    gastric cancer 0 20 17380453 (6), 17310852 (3), 19885581 (3), 16273224 (1) (see all 5)
    cardiac hypertrophy 0 2 16543730 (2)
    prostate carcinoma 0 5 17639041 (2), 20102399 (1), 14743383 (1)
    mental retardation 0 1 15800193 (1)
    colon carcinoma 0 2 15322085 (1), 19568785 (1)
    adenocarcinoma 0 6 15946565 (3), 17210696 (1), 17895832 (1)
    vascular diseases 0 2 15149850 (1)
    brain tumors 0 1 10958682 (1)
    neurofibrillary tangles 0 2 15857667 (1), 15715661 (1)
    nsclc 0 10 20159991 (4), 18224693 (4), 18644989 (1), 18611285 (1)
    leukemogenesis 0 2 18354486 (1), 11707444 (1)
    medulloblastoma 0 2 12517790 (1)
    alzheimers disease 0 1 15715661 (1)
    carcinoma 0 12 15946565 (3), 20102399 (2), 11606581 (2), 17047397 (1) (see all 7)
    lymphoma 0 5 16784226 (1), 15964830 (1), 12897143 (1), 20350533 (1)
    obesity 0 4 17452018 (1), 18573875 (1), 16179727 (1), 11080610 (1)
    cell damage 0 6 13130504 (2), 17203200 (1)
    diabetes mellitus 0 2 15590659 (1), 15010337 (1)
    melanoma 0 9 18579561 (3), 12926238 (1), 11593437 (1), 12622791 (1) (see all 6)
    hyperplasia 0 4 19898424 (1)
    schwannoma 0 2 15837555 (1)
    carcinoma renal cell 0 3 18243508 (1), 18243501 (1), 11551917 (1)

    Genetic Association Database (GAD): AKT1
    Human Genome Epidemiology (HuGE) Navigator: AKT1 (87 documents)
    Tumor Gene Database (TGDB): AKT1

    Export disorders for AKT1 gene to outside databases

    (in PubMed. Associations of this gene to articles via 1Entrez Gene, 2UniProtKB/Swiss-Prot, 3HGNC, 4GAD, 5PharmGKB, 6HMDB, 7DrugBank, 8UniProtKB/TrEMBL, 9 Novoseek, and/or 10fRNAdb)
    About This Section

    PubMed articles for AKT1 gene, integrated from 9 sources (see all 3051):
    (articles sorted by number of sources associating them with AKT1)
        Utopia: connect your pdf to the dynamic
    world of online information

    1. Isolation and characterization of the human AKT1 gene, identification of 13 single nucleotide polymorphisms (SNPs), and their lack of association with Type II diabetes. (PubMed id 11508278)1, 2, 4, 9 Matsubara A....Permutt M.A. (2001)
    2. Association of polymorphisms in AKT1 and EGFR with cl inical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib. (PubMed id 20159991)1, 4, 9 Giovannetti E....Tibaldi C. (2010)
    3. Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. (PubMed id 19164214)1, 4, 9 Hildebrandt M.A....Wu X. (2009)
    4. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. (PubMed id 17915974)1, 4, 9 Xu M.Q....He L. (2007)
    5. Association of AKT1 with schizophrenia confirmed in a Japanese population. (PubMed id 15522255)1, 4, 9 Ikeda M....Ozaki N. (2004)
    6. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic ro les for BRAF, PIK3CA, and AKT1. (PubMed id 19487299)1, 4, 9 Ricarte-Filho J.C....Fagin J.A. (2009)
    7. The actin-bundling protein palladin is an Akt1-specif ic substrate that regulates breast cancer cell migration. (PubMed id 20471940)1, 2, 9 Chin Y.R. and Toker A. (2010)
    8. AKT1 Gene Polymorphisms and Obstetric Complications i n the Patients with Schizophrenia. (PubMed id 20046382)1, 4, 9 Joo E.J....Kim Y.S. (2009)
    9. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. (PubMed id 16583435)1, 4, 9 Bajestan S.N....Osame M. (2006)
    10. AKT1 polymorphisms are associated with tuberculosis i n the Chinese population. (PubMed id 20141546)1, 4, 9 Wang X....Cheng X. (2010)

    (in PubMed, OMIM, and NCBI Bookshelf)
    About This Section
     ANDOR
    Aliases
    Disorders
    Free Text  

      Query String
    PubMed
    OMIM
    NCBI Bookshelf
      (Note: In FireFox, select the above section and copy using Ctrl-C)

    (According to Entrez Gene, HGNC, AceView, euGenes, Ensembl, miRBase, ECgene, Kegg, and/or H-InvDB)
    About This Section
    Entrez Gene: 207 HGNC: 391 AceView: AKT1 Ensembl:ENSG00000142208 euGenes: HUgn207
    ECgene: AKT1 Kegg: 207 H-InvDB: AKT1

    (According to HUGE)
    About This Section
      --

    (According to PharmGKB, ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL,
    Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot)
    About This Section
    NameDescription
    PharmGKB entry for AKT1 Pharmacogenomics, SNPs, Pathways
    ATLAS Chromosomes in Cancer entry for AKT1 Genetics and Cytogenetics in Oncology and Haematology

    (Patent information from GeneIP,
    Licensable technologies from WIS Yeda, Salk, Tufts,
    IP news from LifeMap Sciences, Inc.)
    About This Section
    Patent Information for AKT1 gene:
    Search GeneIP for patents involving AKT1

    Licensable Technologies for AKT1 gene:
     Salk Institute: Protein Kinase B/AKT Modulators and Methods of Use Thereof
     Tufts University:  Regulation of Oncogenesis by Akt-Specific Isoforms
    GeneCards and IP:
    Japan Patent Office Licenses GeneCards     European Patent Office Licenses GeneCards     Improving the IP Search



    (Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, SABiosciences, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Cloud-Clone Corp., Thermo Fisher Scientific, LSBio, Gene Editing from DNA2.0 and Sirion Biotech, Clones from EMD Millipore, OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Sirion Biotech, Cell lines from GenScript, and LifeMap BioReagents, PCR Arrays from SABiosciences, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, and/or Enzo Life Sciences, In Situ Hybridization Assays from
    Advanced Cell Diagnostics, Animal models from inGenious Targeting Laboratory, genOway)
    About This Section

     Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
     EMD Millipore Mono- and Polyclonal Antibodies for the study of AKT1
     EMD Millipore RNAi Products for the Analysis of AKT1 Gene knock-down
     EMD Millipore Kits and Assays for the Analysis of AKT1
     EMD Millipore Purified and/or Recombinant AKT1 Protein
     EMD Millipore small molecules (inhibitor) for AKT1
     
     EMD Millipore Custom Antibody & Bulk Services
     EMD Millipore Preclinical / Clinical Development Services
     EMD Millipore Immunoassay Services
     EMD Millipore Target Screening & Profiling Services

      
     Antibodies for AKT1 (Akt1)   Browse Cell Culture Products  
     ELISAs for AKT1 (Akt1)   Browse Flow Cytometry Kits  
     Browse Primer Pairs   Browse Kinase Activity Assays/Reagents  
     Browse ELISpot Kits/Development Modules   Browse TFB/Immunoprecipitation Assays  
     Browse Apoptosis Detection Kits/Reagents   Browse Ubiquitin Proteasome Pathway (UPP) Assay Kits/Reagents  
     Browse DNA Damage/Repair Kits/Reagents   Browse Multiplex/Array Assay Kits/Reagents  
     Browse Cell Selection/Detection Kits/Reagents   Browse Secondary Antibodies/Controls/Staining Reagents  
     Browse Protease Activity Assays and Reagents   Recombinant/Natural Proteins for AKT1 (Akt1)  
     Browse Stem Cell Products   Browse Tocris Biochemicals & Compounds  
     Browse cDNA Clones   Proteome Profiler Antibody Arrays for AKT1 (Akt1)  
     OriGene Antibodies for AKT1   OriGene RNAi products in human, mouse, rat for AKT1  
     OriGene qPCR primer pairs and template standards for AKT1   OriGene Protein Over-expression Lysate for AKT1  
     OriGene MassSpec something-or-other for AKT1   OriGene clones in human, mouse for AKT1  
     OriGene qSTAR qPCR primer pairs in human, mouse for AKT1   OriGene Purified Protein for AKT1  
     OriGene ORF clones in mouse, rat for AKT1   OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling  
     OriGene Custom Antibody Services for AKT1   OriGene Custom Protein Services for AKT1  

     
     
     QIAGEN Custom miScript Target Protector blocks miRNA-binding site of in human, mouse, rat AKT1
     QIAGEN SeqTarget long-range PCR primers for resequencing AKT1
     QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat AKT1
     QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat AKT1
     QIAGEN QuantiFast Probe-based Assays in human, mouse, rat AKT1
     QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat AKT1
     GenScript Custom Purified and Recombinant Proteins Services for AKT1 GenScript cDNA clones with any tag delivered in your preferred vector for AKT1
     GenScript AKT1-Activity-based Kinase Assay for Compound Screening GenScript Superior Antibodies for AKT1
     GenScript Custom overexpressing Cell Line Services for AKT1 CloneReady with Over 120,000 Genes
     Gene Synthesis: Any Gene in Any Vector Vector-based siRNA and miRNA, Ready for Transfection
     Gene Mutant Library, Variants up to 10^11 Plasmid Preparation
     Custom Peptide Services
     Antibodies & Assays for AKT1 

     Regulatory tfbs in AKT1 promoter
     Search Chromatin IP Primers for AKT1
     RT2 qPCR Primer Assay in human, mouse, rat AKT1
     GNC Network for AKT1
     SABiosciences PCR Arrays including human, mouse, rat AKT1
     Tocris compounds for AKT1
     Proteins and Antibodies for AKT1
     Cell Lysates for AKT1
     cDNA Clones for AKT1
     4000+ Proteins
     Search Sino Biological for antibodies, proteins & pathways
     Protein Production Services
     Transfection Reagents
     Protein A/G/L resins
     Isotyping reagents
     Assays/Proteins for AKT1
     Search www.enzolifesciences.com for proteins, assays, substrates, inhibitors & antibodies
     Novus Tissue Slides
     AKT1 antibodies
     AKT1 proteins
     AKT1 lysates
     Antibodies for AKT1
     See all of Abcam's Antibodies, Kits and Proteins for AKT1
     Custom Antibody / Protein Production Service
     Bulk Purchasing
     Advantages of Rabbit Monoclonal antibodies
     Abcam protocols and scientific support
     Recombinant Protein for AKT1




     Browse Proteins at Cloud-Clone Corp.
     Browse Antibodies at Cloud-Clone Corp.
     Browse ELISAs at Cloud-Clone Corp.
     Browse CLIAs at Cloud-Clone Corp.
     Search LifeMap BioReagents cell lines for AKT1
     Gene Synthesis
     Protein Engineering
     Variant Library Synthesis
     Codon Optimization
     Protein Production and Purification
     Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for AKT1
     SwitchGear 3'UTR luciferase reporter plasmids for AKT1
     SwitchGear Promoter luciferase reporter plasmids for AKT1
     ThermoFisher Antibody for AKT1
     Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat AKT1
     inGenious Targeting Laboratory - Custom generated mouse model solutions for AKT1
     inGenious Targeting Laboratory - Custom generated inducible mouse model solutions for AKT1
     Validated adenovirus to knockdown AKT1 in human, mouse

    Customized:
     lentivirus for stable overexpression of AKT1
     lentivirus expression plasmids for stable overexpression of AKT1
     adenovirus for overexpression of AKT1
     LSBio Antibodies in human, mouse, rat for AKT1
    Customized transgenic rodents for:
     Humanization
     Biomarker expression
     Off-target effect monitoring
     Translational medicine
     Tissue-specific gene expresssion
     Time-controlled gene expresssion
           
    GeneCards Homepage - Last full update: 23 Oct 2013 - Incrementals: 4 Nov 2013 , 7 Nov 2013 , 23 Jan 2014

    View Random Gene

    Category
    (GIFtS: 73)
    transforming growth factor, beta 1
    GIFtS Group
    The GeneCards human gene database gene index: 1 3 5 6 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 


    Developed at the Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science

    Hot genes      Disease genes      AKT1 gene at Home site.
    hostname: 356977-web1.xennexinc.com index build: 106 solr: 1.4